Here's why they think Eli Lilly (NYSE: LLY), Summit Therapeutics (NASDAQ: SMMT), and Vertex Pharmaceuticals (NASDAQ: VRTX) could trounce the market in 2025. David Jagielski (Eli Lilly): For years ...
Get the full experience! Unlock access to all videos with the Unlimited Trains.com Membership.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback